APOLLO FMG (00860) completes placement of a total of 75 million placement shares
APOLLO FMG (00860) announces that all conditions set out in the placing agreement dated October 8, 2026 (as supplemented by the supplemental placing agreement dated October 11, 2026, collectively the "Placing Agreement") have been fulfilled, and completion of the placing took place on November 4, 2026 in accordance with the terms of the Placing Agreement. The placing agent has successfully placed a total of 75 million placing shares to three placees at a placing price of HK$0.59 per placing share in accordance with the terms and conditions of the Placing Agreement, representing approximately 7.34% of the issued share capital of the Company immediately before the placing and approximately 6.83% of the issued share capital of the Company as enlarged by the allotment and issue of all the placing shares as at the date of this announcement.
APOLLO FMG (00860) announces that all conditions set out in the placing agreement dated October 8, 2026 (as supplemented by the supplemental placing agreement dated October 11, 2026, collectively the "Placing Agreement") have been fulfilled, and completion of the placing took place on November 4, 2026 in accordance with the terms of the Placing Agreement. The placing agent has successfully placed a total of 75,000,000 placing shares to three placees at the placing price of HK$0.59 per placing share in accordance with the terms and conditions of the Placing Agreement, representing approximately 7.34% of the Company's issued share capital immediately before the placing and approximately 6.83% of the Company's issued share capital as enlarged by the allotment and issue of all the placing shares as at the date of this announcement.
As the number of placees is fewer than six, and pursuant to Rule 13.28(7) of the Listing Rules, the Company is required to disclose in this announcement the names of the placees, namely Fusion International (Singapore) Pte. Ltd., a company incorporated in Singapore and indirectly wholly owned by Mr. Qiu Yufeng; Ms. Zhou Xiaocen, an individual investor; and Mr. Luo Hongbo, an individual investor.
Related Articles

BRII-B (02137) repurchased 320,000 shares on November 4 for approximately HK$322,200.

Sanofi (SNY.US) Halts STAT6 Program; Nurix (NRIX.US) Falls Over 30% in Pre-Market! Milestone Payments and Revenue Sharing Both Fall Through

JST GROUP (06687) repurchased 35,400 shares on November 4 for approximately HK$376,300.
BRII-B (02137) repurchased 320,000 shares on November 4 for approximately HK$322,200.

Sanofi (SNY.US) Halts STAT6 Program; Nurix (NRIX.US) Falls Over 30% in Pre-Market! Milestone Payments and Revenue Sharing Both Fall Through

JST GROUP (06687) repurchased 35,400 shares on November 4 for approximately HK$376,300.






